Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation
Bondong, S., Kiefel, H., Hielscher, T., Zeimet, A.G., Zeillinger, R., Pils, D., Schuster, E., Castillo-Tong, D.C., Cadron, I., Vergote, I., Braicu, I., Sehouli, J., Mahner, S., Fogel, M., Altevogt, P.
Published in Annals of oncology (01.07.2012)
Published in Annals of oncology (01.07.2012)
Get full text
Journal Article
Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer
Reimer, D, Hubalek, M, Kiefel, H, Riedle, S, Skvortsov, S, Erdel, M, Hofstetter, G, Concin, N, Fiegl, H, Müller-Holzner, E, Marth, C, Altevogt, P, Zeimet, A G
Published in Oncogene (22.09.2011)
Published in Oncogene (22.09.2011)
Get full text
Journal Article
An uncommon case of POLE mutated uterine carcinosarcoma − complemented by a review of literature
Ebner, C., Frosch, A., Leitner, K., Soucek, R., Marth, C., Zeimet, AG
Published in Gynecologic oncology reports (01.08.2024)
Published in Gynecologic oncology reports (01.08.2024)
Get full text
Journal Article
Adjuvante Therapie des Endometriumkarzinoms
Mallmann, P., Vordermark, D., Feyer, P., Hagen, V., Höcht, S., Niehoff, P., Petru, E., Zeimet, A.-G., Micke, O., Battista, M. J.
Published in Gynäkologie (Heidelberg, Germany) (01.07.2022)
Published in Gynäkologie (Heidelberg, Germany) (01.07.2022)
Get full text
Journal Article
The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma — Analysis of patient data in the prospective OVCAD study
Hofstetter, G, Concin, N, Braicu, I, Chekerov, R, Sehouli, J, Cadron, I, Van Gorp, T, Trillsch, F, Mahner, S, Ulmer, H, Grimm, C, Castillo-Tong, D. Cacsire, Zeillinger, R, Zeimet, A.G, Vergote, I
Published in Gynecologic oncology (01.10.2013)
Published in Gynecologic oncology (01.10.2013)
Get full text
Journal Article
Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas
ZEIMET, A. G, MÜLLER-HOLZNER, E, SCHULER, A, HARTUNG, G, BERGER, J, HERMANN, M, WIDSCHWENDTER, M, BERGELSON, J. M, MARTH, C
Published in Gene therapy (01.08.2002)
Published in Gene therapy (01.08.2002)
Get full text
Journal Article
Adjuvante Therapie des Endometriumkarzinoms
Mallmann, P., Höcht, S., Vordermark, D., Zeimet, A.‑G., Petru, E., Feyer, P., Letsch, A., Hagen, V.
Published in Gynäkologe (Berlin) (01.12.2018)
Published in Gynäkologe (Berlin) (01.12.2018)
Get full text
Journal Article
P132 Significance of locus-specific TP53 mutations in ovarian cancer
Knoll, K, Berger, A, Tsibulak, I, Leitner, K, Degasper, C, Welponer, H, Wieser, V, Marth, C, Fiegl, H, Zeimet, A-G
Published in International journal of gynecological cancer (01.11.2019)
Published in International journal of gynecological cancer (01.11.2019)
Get full text
Journal Article
Loss of retinoic acid receptor β expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer
WIDSCHWENDTER, M, BERGER, J, DAXENBICHLER, G, MÜLLER-HOLZNER, E, WIDSCHWENDTER, A, MAYR, A, MARTH, C, ZEIMET, A. G
Published in Cancer research (Chicago, Ill.) (01.10.1997)
Get full text
Published in Cancer research (Chicago, Ill.) (01.10.1997)
Journal Article
Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1)
Roser, Eva, Harter, Philipp, Zocholl, Dario, Denschlag, Dominik, Chekerov, Radoslav, Wimberger, Pauline, Kurzeder, Christian, Hasenburg, Annette, Muallem, Mustafa-Zelal, Mustea, Alexander, Emons, Guenter, Zeimet, A G, Beck, Felix, Arndt, Tjadina, Brucker, Sara Y, Kommoss, Stefan, Heitz, Florian, Welz, Julia, Egger, Eva-Katharina, Kalder, Matthias, Buderath, Paul, Klar, Maximilian, Marth, Christian, Ulrich, Uwe Andreas, Weigel, Michael, Traub, Lea, Anthuber, Christoph, Strauss, Hans, Hanker, Lars, Link, Theresa, Kubiak, Karol, Melekian, Badrig, Hornung, Daniela, Pölcher, Martin, Lampe, Bjoern, Krauß, Thomas, Keilholz, Ulrich, Flörcken, Anne, Pietzner, Klaus, Sehouli, Jalid
Published in International journal of gynecological cancer (01.02.2023)
Published in International journal of gynecological cancer (01.02.2023)
Get full text
Journal Article
713 Palbociclib and metformin show anticancer efficacy in high grade serous ovarian cancer
Tsibulak, I, Hagenbuchner, J, Ausserlechner, M, Kögl, J, Marth, C, Zeimet, AG, Fiegl, H
Published in International journal of gynecological cancer (12.10.2021)
Published in International journal of gynecological cancer (12.10.2021)
Get full text
Journal Article
Alternative splicing of p53 and p73: the novel p53 splice variant p53[delta] is an independent prognostic marker in ovarian cancer
Hofstetter, G, Berger, A, Fiegl, H, Slade, N, Zoric, A, Holzer, B, Schuster, E, Mobus, V J, Reimer, D, Daxenbichler, G, Marth, C, Zeimet, A G, Concin, N, Zeillinger, R
Published in Oncogene (01.04.2010)
Published in Oncogene (01.04.2010)
Get full text
Journal Article
Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer
Zeimet, A G, Widschwendter, M, Knabbe, C, Fuchs, D, Herold, M, Müller-Holzner, E, Daxenbichler, G, Offner, F A, Dapunt, O, Marth, C
Published in Journal of clinical oncology (01.05.1998)
Published in Journal of clinical oncology (01.05.1998)
Get more information
Journal Article
Expression III: patients’ expectations and preferences regarding physician–patient relationship and clinical management—results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries
Oskay-Özcelik, G., Alavi, S., Richter, R., Keller, M., Chekerov, R., Cecere, S.C., Cormio, G., Joly, F., Kurtz, J.E., du Bois, A., Maciejewski, M., Jedryka, M., Vergote, I., Van Nieuwenhuysen, E., Casado, A., Mendiola, C., Achimas-Cadariu, P., Vlad, C., Reimer, D., Zeimet, A.G., Friedlander, M., Sehouli, J.
Published in Annals of oncology (01.04.2018)
Published in Annals of oncology (01.04.2018)
Get full text
Journal Article
Predictive value of uPA, PAI-1, HER-2 and VEGF in the serum of ovarian cancer patients
Abendstein, B, Daxenbichler, G, Windbichler, G, Zeimet, A G, Geurts, A, Sweep, F, Marth, C
Published in Anticancer research (01.01.2000)
Get more information
Published in Anticancer research (01.01.2000)
Journal Article
Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
Hofstetter, G, Berger, A, Fiegl, H, Slade, N, Zorić, A, Holzer, B, Schuster, E, Mobus, V J, Reimer, D, Daxenbichler, G, Marth, C, Zeimet, A G, Concin, N, Zeillinger, R
Published in Oncogene (01.04.2010)
Published in Oncogene (01.04.2010)
Get full text
Journal Article
Long-term significance of urinary neopterin in ovarian cancer: a study by the Austrian Association for Gynecologic Oncology (AGO)
Volgger, B.M., Windbichler, G.H., Zeimet, A.G., Graf, A.H., Bogner, G., Angleitner-Boubenizek, L., Rohde, M., Denison, U., Sliutz, G., Fuith, L.C., Fuchs, D., Marth, C.
Published in Annals of oncology (01.09.2016)
Published in Annals of oncology (01.09.2016)
Get full text
Journal Article
Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
Hofstetter, G, Berger, A, Schuster, E, Wolf, A, Hager, G, Vergote, I, Cadron, I, Sehouli, J, Braicu, E I, Mahner, S, Speiser, P, Marth, C, Zeimet, A G, Ulmer, H, Zeillinger, R, Concin, N
Published in British journal of cancer (08.11.2011)
Published in British journal of cancer (08.11.2011)
Get full text
Journal Article
EP891 Receptor activator of nuclear factor kappa-B ligand expression predicts ovarian cancer outcome
Kögl, J, Wieser, V, Sprung, S, Fiegl, H, Marth, C, Zeimet, AG
Published in International journal of gynecological cancer (01.11.2019)
Published in International journal of gynecological cancer (01.11.2019)
Get full text
Journal Article